PopVax funding, investors and company details

PopVax is an emerging Healthcare startup from Hyderabad, working in the space of Novel mRNA vaccines and cancer immunotherapies. Founded by Soham Sankaran.

Company: PopVax Private Limited
Sector: Healthcare
Location: Hyderabad
Founders: Soham Sankaran
Total funding raised: ₹9.72 Cr

Company overview

PopVax develops novel mRNA vaccines and cancer immunotherapies using machine learning-driven computational protein design and lipid nanoparticle delivery platforms. The Hyderabad-based biotech focuses on broadly-protective candidates against infectious diseases like COVID-19, HCV, TB, influenza, HPV, and Strep A, alongside precision treatments for solid tumors such as liver and pancreatic cancer. It operates an integrated R&D and GMP-capable facility called the RNA Foundry, aiming to produce affordable, thermostable vaccines at scale for global distribution, particularly in low-income countries.

Funding rounds

Latest round: $ 1.15 Mn (₹9.72 Cr.), 2024-11-01. Investors: Bill & Melinda Gates Foundation